. Levels of activation can be modulated by variations in these interactions, resulting from changes in diverse parameters such as promoter structure (e.g., the number of activatorbinding sites), activator properties (e.g., activation potency), and cellular environment (e.g., activator concentration). Indeed, it is the combined effects of many parameters such as these that ultimately determine the level of transcription of a gene under a given cellular circumstance.
The combined effects of these multiple parameters have been investigated in vivo in diverse systems (5) (6) (7) (8) (9) (10) . While the results of these studies have shown that transcriptional effects caused by changes in these various parameters are often interdependent (5-10), they have recurrently revealed one important aspect in transcriptional regulation-synergistic transcriptional responses to parameter changes. Thus, an increase in the number of activator-binding sites often results in synergistic increases in transcription (5, (8) (9) (10) , and a moderate increase in activator concentration can induce steep transcriptional responses (6) .
In theory, the levels of transcription from a promoter can be modulated by either changes in the levels of activator binding to a promoter or changes in the efficacy of the promoter-bound activators to give rise to distinct transcriptional outcomes (e.g., The (13) . The effectors contained the epitope tag and the nuclear localization signal (Met-SerSer-Tyr-Pro-Pro-Tyr-Asp-Val-Pro-Asp-Tyr-Ala-Ser-Leu-GlyGly-Pro-Ser-Ser-Pro-Pro-Lys-Lys-Lys-Lys-Lys-Arg-Lys-ValSer-Ser; refs. 14 and 15), followed by the Oct-2 POU-domain sequence (24) .
RESULTS
Experimental Design. Fig. 1 (17) (18) (19) . This reiteration strategy allowed modulation of activation potency by varying the number of VN8 modules without introducing a qualitative alteration in activation-domain function; activators with increasing number of reiterated VN8 module activated transcription more efficiently, whereas the POU domain alone, although selectively localized in the nucleus, did not activate transcription efficiently (see below; and data not shown). The VN8 module was one of the most potent in activating transcription among several tested (e.g., see Fig. 3 ), yet it had no effect on yeast cell growth under the experimental conditions described in the present work. To modulate activator concentration, expression of these POU-domain-containing activators was regulated with the inducible GALl promoter (Fig. la) . Finally, to examine the effects of the number of activatorbinding sites in a promoter, a set of test promoters, which contained one, two, or six tandem copies of the Oct-2 POUdomain-binding site (the octamer sequence), were fused upstream of the E. coli lacZ reporter gene (Fig. lb) Fig. 2 a and b) . In contrast, all the effectors failed to bind effectively to the lx site promoter (lanes 11-13, 23-25, and 35-37; see also a quantitation in Fig. 2c) (Fig. 2) . For example, to achieve relatively similar levels of binding to the 2x site promoter in vivo (Fig. 2a, lanes 15-17, 27-29 , and 39-41), the DNA-binding domain alone required significantly higher levels of expression (lanes 15-17 in Fig. 2b ) than either the strong 6x VN8 (lanes 39-41 in Fig. 2b ) or weak 2x VN8 (lanes 27-29 in Fig. 2b) activators. Indeed, quantitation of these results ( Fig. 2c; 1-9) shows the results with negative control samples, which contained either yeast DNA methylated by DMS Fig. 2d. A compar- ison among different promoters revealed that the 2x site promoter directs 10-fold higher levels of transcription than the 1 x site promoter with either the weak 2x VN8 activator (the center graph in Fig. 2d) Fig. 2c ).
Comparison of the transcriptional efficacy of activatorbound promoters, however, was possible between the 2x and 6x site promoters. This comparison revealed that, at similar levels of in vivo occupancy by the 2x VN8 activator, these two promoters direct similar levels of transcription ( Fig. 2e ; the center graph). Thus, the 6x site promoter achieves higher levels of transcription than the 2x site promoter at equivalent activator concentrations ( Fig. 2d ; the center graph) predominantly because the activator is more readily recruited to the 6x site promoter than to the 2x site promoter ( Fig. 2c; module and other VP16-derived activation modules; each was fused to the Oct-2 POU DNA-binding domain. These activators were assayed for their levels of expression, in vivo site occupancy, and transcriptional activation with the 2x site promoter as described for Fig. 2. (Right) Results of these assays; the upper graph shows levels of activators required for half-optimal site occupancy in vivo, and the lower graph shows respective levels of transcription. Plotted values were obtained either from a single data point, which displayed near half-optimal site occupancy (46-53% protection), or from the interpolation of a pair of data points, one of which displayed site occupancy lower than halfoptimal (29-40% protection) and the other displayed site occupancy higher than half-optimal (58-65% protection). In the latter cases, actual levels of activators and transcription from these pairs of data points are shown as upper and lower limits of error bars. the 6x VN8 activator achieves 40-fold higher levels of transcription than the 2x VN8 activator relative to activator levels ( Fig. 2d ; compare the right and center graphs). This 40-fold difference in the steepness of transcriptional responses can be attributed to both (i) the 4-fold difference in transcriptional activation by promoter-bound activators (Fig. 2e) , and (ii) the 10-fold difference in activator binding to the promoter (Fig.  2c) (Fig. 3) . The results displayed in Fig. 3 (27) (28) (29) but also to the presence of activation domains (30) . Therefore, although the significance of these in vitro effects has yet to be verified in vivo, it is possible that activation domains augment activator binding to DNA and transcription through diverse pathways yet via a common or similar target(s).
Transcriptional efficacy of a promoter is determined through integration of numerous parameters via multitudes of protein-protein and protein-DNA interactions. In this entire process, modulation of interactions between promoter-bound activators and general transcription factors have been broadly accepted to produce specific transcriptional outcomes from a promoter. Indeed, by modulating these interactions, potency of activation domains and the number of binding sites can impact on transcription in vitro (31, 32 
